Retrospective analysis of chronic hepatitis D in a West German university clinic over two decades: Migratory pattern, prevalence and clinical outcome

Zeitschrift fur Gastroenterologie

Volumn 48, Issue 8, 2010, Pages 813-817

  Erhardt, A ^a   Hoernke, M ^a   Heinzel Pleines, U ^a   Sagir, A ^a   Gobel T ^a   Haussinger D ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Cirrhosis; Hepatitis D; Interferon

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; PEGINTERFERON; PEGINTERFERON ALPHA; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B;

ADOLESCENT; ADULT; AFRICA; ANTIVIRAL THERAPY; ARTICLE; ASCITES; BACTERIAL PERITONITIS; CHILD; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DISEASE COURSE; DISEASE DURATION; DISEASE FREE SURVIVAL; ESOPHAGUS VARICES; EUROPE; FEMALE; GERMANY; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS DELTA VIRUS; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIGRATION; MORTALITY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PREVALENCE; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIVERSITY HOSPITAL; USSR; VIROLOGY; VIRUS REPLICATION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; CHILD; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; FEMALE; GERMANY; HEPATITIS D, CHRONIC; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; RETROSPECTIVE STUDIES; STUDENT HEALTH SERVICES; SURVIVAL ANALYSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 77955343880     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1109984     Document Type: Article

References (33)

1. Rizzetto M. Hepatitis D: thirty years after. J Hepatol 2009 50 1043-1050
2. Farci P. Delta hepatitis: an update. J Hepatol 2003 39 (Suppl 1) S212-S219
3. Erhardt A, Knuth R, Sagir A et al. Socioepidemiological data on hepatitis delta in a German university clinic increase in patients from Eastern Europe and the former Soviet Union. Z Gastroenterol 2003 41 523-526
4. Flodgren E, Bengtsson S, Knutsson M et al. Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains. J Clin Microbiol 2000 38 3311-3316
5. Gaeta G B., Stroffolini T, Chiaramonte M et al. Chronic hepatitis D: a vanishing disease? An Italian multicenter study. Hepatology 2000 32 824-827
6. Rosina F, Conoscitore P, Cuppone R et al. Changing pattern of chronic hepatitis D in Southern Europe. Gastroenterology 1999 117 161-166
7. Sagnelli E, Stroffolini T, Ascione A et al. The epidemiology of hepatitis delta infection in Italy. Promoting Group. J Hepatol 1992 15 211-215
8. Hadziyannis S J., Dourakis S P., Papaioannou C et al. Changing epidemiology and spreading modalities of hepatitis delta virus infection in Greece. Prog Clin Biol Res 1993 382 259-266
9. Degertekin H, Yalcin K, Yakut M et al. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis. Liver Int 2008 28 494-498
10. Fattovich G, Boscaro S, Noventa F et al. Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. J Infect Dis 1987 155 931-935
11. Fattovich G, Giustina G, Christensen E et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut 2000 46 420-426
12. Niro G A., Ciancio A, Gaeta G B. et al. Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. Hepatology 2006 44 713-720
13. Niro G A., Rosina F, Rizzetto M. Treatment of hepatitis D. J Viral Hepat 2005 12 2-9
14. Erhardt A, Gerlich W, Starke C et al. Treatment of chronic hepatitis delta with pegylated interferon-alpha2b. Liver Int 2006 26 805-810
15. Castelnau C, Le Gal F, Ripault M P. et al. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology 2006 44 728-735
16. Gunsar F, Akarca U S., Ersoz G et al. Two-year interferon therapy with or without ribavirin in chronic delta hepatitis. Antivir Ther 2005 10 721-726
17. Kaymakoglu S, Karaca C, Demir K et al. Alpha interferon and ribavirin combination therapy of chronic hepatitis D. Antimicrob Agents Chemother 2005 49 1135-1138
18. Rizzetto M, Verme G, Recchia S et al. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med 1983 98 437-441
19. Saracco G, Rosina F, Brunetto M R. et al. Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection. J Hepatol 1987 5 274-281
20. Verme G, Brunetto M R., Oliveri F et al. Role of hepatitis delta virus infection in hepatocellular carcinoma. Dig Dis Sci 1991 36 1134-1136
21. Desmet V J., Gerber M, Hoofnagle J H. et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994 19 1513-1520
22. Le Gal F, Castelnau C, Gault E et al. Hepatitis D virus infection not a vanishing disease in Europe. Hepatology 2007 45 1332-1333
23. Cross T J., Rizzi P, Horner M et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol 2008 80 277-282
24. Wedemeyer H, Heidrich B, Manns M P. Hepatitis D virus infection not a vanishing disease in Europe. Hepatology 2007 45 1331-1332, author reply 1332 1333
25. Kalinin A L., Zhavoronok S V., Mikhailov M I. et al. Viral hepatitis delta in the republic of Belarus. Zh Mikrobiol Epidemiol Immunobiol 1998 6 74-77
26. Trautwein C, Kiral G, Tillmann H L. et al. Risk factors and prevalence of hepatitis E in German immigrants from the former Soviet Union. J Med Virol 1995 45 429-434
27. Romeo R, Del Ninno E, Rumi M et al. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology 2009 136 1629-1638
28. Colombo M, Cambieri R, Rumi M G. et al. Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis. Gastroenterology 1983 85 235-239
29. Smedile A, Farci P, Verme G et al. Influence of delta infection on severity of hepatitis B. Lancet 1982 2 945-947
30. Pugnale P, Pazienza V, Guilloux K et al. Hepatitis delta virus inhibits alpha interferon signaling. Hepatology 2009 49 398-406
31. Lau D T., Kleiner D E., Park Y et al. Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy. Gastroenterology 1999 117 1229-1233
32. Rodriguez-Torres M, Jeffers L J., Sheikh M Y. et al. Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C. N Engl J Med 2009 360 257-267
33. Muir A J., Bornstein J D., Killenberg P G. Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites. N Engl J Med 2004 350 2265-2271